StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$2.10−0.01 (-0.47%)

Close on Nov 18, 2026Market cap $213.66MP/E –Yield –

AC Immune operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

AC Immune's operating cash flow for the twelve months ending Dec 31, 2022 was -CHF 73.57M. For fiscal 2025 it was -CHF 69.26M, down 205.2% from the year before. The highest annual figure on record is CHF 65.84M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CHF 69.26M-205.2%
FY2024Dec 31, 2024CHF 65.84M–
FY2023Dec 31, 2023-CHF 60.41M–
FY2022Dec 31, 2022-CHF 73.57M–
FY2021Dec 31, 2021-CHF 65.69M–
FY2020Dec 31, 2020-CHF 59.52M-207.8%
FY2019Dec 31, 2019CHF 55.22M–
FY2018Dec 31, 2018-CHF 44.08M–
FY2017Dec 31, 2017-CHF 22.09M–
FY2016Dec 31, 2016-CHF 5.65M-112.8%
FY2015Dec 31, 2015CHF 44.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-CHF 17.41M–
Q3 FY2022Sep 30, 2022-CHF 13.54M–
Q4 FY2021Dec 31, 2021-CHF 17.83M–

More AC Immune figures

See a number that looks wrong?